BIO-Europe 2025: ORGANOPlus Strengthens Global Partnerships in Vienna

ORGANOPlus participated in BIO-Europe 2025 held in Vienna, Austria,meeting with over 30 leading European biopharma companies and exploring collaborationswith key research institutes in the Czech Republic and Germany to advance its organoid-on-chip technology.

The company discussed joint development of SOPs and reproducibility enhancementwith the International Clinical Research Center (ICRC) in Brno, Czech Republic,and explored multi-organ chip development with the Max Planck Institute for Heart and Lung Research in Germany.These partnerships are expected to serve as a foundation for standardizing organoid-based precision medicineand non-animal preclinical testing across Europe.